Revvity (RVTY) EPS (Diluted) Growth (1y) (2010 - 2026)
Revvity (RVTY) EPS (Diluted) Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.44 Bn | 209.37 Bn | 8.34 Bn | 10.71% |
| 2 | Danaher | 139.95 Bn | 135.60 Bn | 3.61 Bn | 59.30% |
| 3 | Idexx Laboratories | 46.16 Bn | 45.96 Bn | 779.09 Mn | 17.55% |
| 4 | Agilent Technologies | 39.67 Bn | 37.87 Bn | 990.00 Mn | 58.79% |
| 5 | Iqvia Holdings | 39.29 Bn | 37.21 Bn | 1.44 Bn | -6.55% |
| 6 | Natera | 38.61 Bn | 37.51 Bn | 696.04 Mn | -21.08% |
| 7 | Illumina | 29.99 Bn | 28.82 Bn | 770.00 Mn | -9.61% |
| 8 | Mettler Toledo International | 28.57 Bn | 28.51 Bn | 650.22 Mn | 18.37% |
| 9 | Quest Diagnostics | 26.17 Bn | 25.55 Bn | 1.03 Bn | 13.90% |
| 10 | Revvity | 12.76 Bn | 11.90 Bn | 387.66 Mn | -133.11% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 5, 2026 | -133.11% |
| Dec 28, 2025 | -56.38% |
| Sep 28, 2025 | -161.80% |
| Jun 29, 2025 | 92.24% |
| Mar 30, 2025 | 121.75% |
| Sep 29, 2024 | 104.31% |
| Jun 30, 2024 | 24.06% |
| Mar 31, 2024 | -100.50% |
| Oct 1, 2023 | -247.76% |
| Jul 2, 2023 | -232.12% |
| Apr 2, 2023 | 7,772.27% |
| Jan 1, 2023 | 356.68% |
| Oct 2, 2022 | -28.40% |
| Jul 3, 2022 | -13.41% |
| Apr 3, 2022 | -166.85% |
| Jan 2, 2022 | 8,120.92% |
| Oct 3, 2021 | 53,153.43% |
| Apr 4, 2021 | 18,849.09% |
| Jan 3, 2021 | -51.29% |
| Oct 4, 2020 | 29.31% |